Impact of TPO Treatment on Bone Healing and Angiogenesis in Type 2 Diabetes

TPO 治疗对 2 型糖尿病骨愈合和血管生成的影响

基本信息

  • 批准号:
    9492356
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-07-01 至 2021-06-30
  • 项目状态:
    已结题

项目摘要

Currently, 1 in 4 veterans receiving VA care is diabetic, and over 70% are overweight or obese and at risk of developing diabetes. Diabetes is a risk factor for impaired fracture healing and numerous studies have demonstrated increased frequency of non-union, partial union, or delayed union in diabetic patients as compared to non-diabetic patients. Diabetic patients have impaired microcirculation which is partially responsible for these fracture complications. In the case of non-union, additional interventions are required such as bone grafting techniques. The gold standard for grafting to achieve bone union is the use of autograft from the patient's hip, which may not always achieve healing. Additionally, the harvest of bone often leaves patients with a painful donor site that may not resolve. Therefore, orthopaedic surgeons desire a biologic enhancement for bone healing that does not require the harvesting of iliac crest bone. Local placement of bone morphogenetic proteins (BMPs) is the only FDA approved biological option capable of healing non-unions. BMPs, although potent in promoting bone regeneration, have been associated with several side effects, including a link with cancer. Therefore, there is a great need for new therapies that heal bone with improved safety profiles. Recently, we found that thrombopoietin [TPO, a megakaryocyte (MK) growth factor] could heal critical-sized bone defects in mice, rats and pigs, as well as, if not better than, BMP-2. The long-term goal of this work is to determine whether thrombopoietic agents could serve as novel therapies for bone healing. Our studies as well as the literature show that TPO increases pathways associated with angiogenesis, increases hematopoietic cell populations, including osteoclasts (OCs) and MKs, and increases osteoblasts (OBs) and bone formation, the latter is indirectly through MK-mediated OB proliferation. Based on these ideas, we hypothesize that TPO accelerates bone healing in type 2 diabetes (T2D) by stimulating angiogenesis which has the direct benefit of delivering mesenchymal and hematopoietic cells that mediate wound healing. In Aim 1, we will assess the therapeutic effects of TPO on bone healing in diet-induced obesity with hyperglycemia, hyperinsulinemia, and glucose intolerance (T2D). Mice on a C57BL/6 background will be fed a low fat diet (LFD) or a high fat diet (HFD), will undergo a segmental bone defect surgery, will be treated with saline (negative control), BMP-2 (positive control), or TPO (experimental group), and bone healing assessed. In Aim 2, we will demonstrate the role of TPO in stimulating angiogenesis/vasculogenesis. This will be accomplished by characterizing angiogenesis/vasculogenesis in mice from Aim 1, as well as in mice in which the TPO receptor has been selectively knocked out of endothelial cells (ECs). We will also conduct a series of in vitro studies to assess the impact of TPO treatment as well as secreted factors from MKs on EC function to begin dissecting the mechanisms responsible. Successful accomplishment of these Aims will demonstrate the utility of using TPO for improving bone healing in diabetic patients. This project has high translational potential as thrombopoietic agents are currently FDA approved for treatment of low platelet numbers. Therefore, the regulatory pathway for obtaining FDA approval for a new indication, fracture healing, is easier than it would be for a compound or biologic which has never been used in patients. Finally, demonstrating the mechanism by which TPO stimulates angiogenesis will be important for determining whether other downstream targets should also be evaluated for therapeutic efficacy.
目前,四分之一接受退伍军人事务部护理的退伍军人患有糖尿病,超过70%的人超重或肥胖

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Melissa A Kacena其他文献

Melissa A Kacena的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Melissa A Kacena', 18)}}的其他基金

RR&D Research Career Scientist Award Application
RR
  • 批准号:
    10754152
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
"Novel therapeutic approaches to improve fracture healing while reducing pain behavior"
“改善骨折愈合同时减少疼痛行为的新治疗方法”
  • 批准号:
    10609035
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
"Novel therapeutic approaches to improve fracture healing while reducing pain behavior"
“改善骨折愈合同时减少疼痛行为的新治疗方法”
  • 批准号:
    10426446
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Osteomacs and megakaryocytes interact to regulate hematopoietic stem cell function
骨巨细胞和巨核细胞相互作用调节造血干细胞功能
  • 批准号:
    10212373
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Angiogenic Therapy: Novel Approaches to Enhance Bone Regeneration in Aging - LOAD
血管生成疗法:增强衰老过程中骨再生的新方法 - LOAD
  • 批准号:
    10711847
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Osteomacs and megakaryocytes interact to regulate hematopoietic stem cell function
骨巨细胞和巨核细胞相互作用调节造血干细胞功能
  • 批准号:
    9764740
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Angiogenic Therapy: Novel Approaches to Enhance Bone Regeneration in Aging - AD/ADRD
血管生成疗法:增强衰老过程中骨再生的新方法 - AD/ADRD
  • 批准号:
    10711880
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
ShEEP Request for a Kubtec XPERT 80 Shielded Cabinet X-ray System
ShEEP 请求 Kubtec XPERT 80 屏蔽柜 X 射线系统
  • 批准号:
    9796215
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Angiogenic Therapy: Novel Approaches to Enhance Bone Regeneration in Aging
血管生成疗法:增强衰老过程中骨再生的新方法
  • 批准号:
    9757972
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Osteomacs and megakaryocytes interact to regulate hematopoietic stem cell function
骨巨细胞和巨核细胞相互作用调节造血干细胞功能
  • 批准号:
    10686056
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了